10% Owner · Wave Life Sciences, Inc. · Wave Life Sciences Ltd.
Side
BUY
Value
$27.93M
Shares
1.47M
Price
$19
Executed
Dec 11, 2025
Disclosed
Dec 15, 2025
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Dec 11 executedDec 15, 2025 disclosed
WVE · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Other disclosed activity · WVE
No records
No other disclosures for this security in the dataset.
Evidence
Verified data
Read directly from the primary public document; every field below is as reported by the filer.
GSK plc filed this Form 4 reporting a open-market purchase of WVE on Dec 11, 2025. It became public on Dec 15, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
10% Owner
GSK plccik:0001131399
Issuer
Wave Life Sciences, Inc.cik:0001631574
Revision history · 0
No field has changed since this record was first ingested.